Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
Bostom
Andrew G
AG
Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island.
D015415:Biomarkers / Q000032:analysis; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality*; D003404:Creatinine / Q000191:economics / Q000652:urine; D005260:Female; D006085:Graft Survival; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects / Q000401:mortality*; D008297:Male; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D015415:Biomarkers; D006710:Homocysteine; D003404:Creatinine